Kana Hashimoto

Statistics

Publications

Citations

113

H-Index

Active since

2019

Affiliations

Tokyo Metropolitan Komagome Hospital(Current)

Kana Hashimoto is an author at Tokyo Metropolitan Komagome Hospital specializing in oncology, non-small cell lung cancer treatment, and pharmacotherapy.

Publications per year

2019–2023

Publications

First-Line Osimertinib for Previously Untreated Patients With NSCLC and Uncommon <i>EGFR</i> Mutations

Yusuke Okuma, Kaoru Kubota, Mototsugu Shimokawa et al. · JAMA Oncology · 2023 · 81 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Association between the baseline tumor size and outcomes of patients with non-small cell lung cancer treated with first-line immune checkpoint inhibitor monotherapy or in combination with chemotherapy

Yuji Uehara, Taiki Hakozaki, Rui Kitadai et al. · Translational Lung Cancer Research · 2022 · 22 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Correlation between the qualification for bevacizumab use and the survival of patients with non-small cell lung cancer harboring the epidermal growth factor receptor mutation: a retrospective analysis

Taiki Hakozaki, Yusuke Okuma, Kana Hashimoto et al. · Journal of Cancer Research and Clinical Oncology · 2019 · 10 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

1–3 of 3